Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody1
- 15 June 2003
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 75 (11) , 1812-1819
- https://doi.org/10.1097/01.tp.0000064622.54799.0e
Abstract
Nonobese diabetic (NOD) mice develop autoimmune diabetes with features similar to those observed in the human disease. The concurrence of allorecognition and recurrence of autoimmunity might explain why most of the treatments successful in preventing islet allograft destruction in other nonautoimmune combinations often fail in NOD recipients. To assess the value of the NOD mouse model for the evaluation of treatments relevant to clinical islet transplantation, the authors have tested the effect of a protocol closely resembling the one successfully used in the Edmonton clinical trial on the survival of islet allografts in NOD miceKeywords
This publication has 20 references indexed in Scilit:
- Combination Therapy With Sirolimus and Interleukin-2 Prevents Spontaneous and Recurrent Autoimmune Diabetes in NOD MiceDiabetes, 2002
- Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic miceDiabetologia, 2002
- Tolerance and pancreatic islet transplantationPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- Prolonged survival of allogeneic islet grafts in NOD mice treated with a combination of anti-CD45RB and anti-CD154 antibodiesTransplantation Proceedings, 2001
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenNew England Journal of Medicine, 2000
- HUMAN ISLET TRANSPLANTATIONTransplantation, 2000
- Diabetes Results from a Late Change in the Autoimmune Response of NOD MiceJournal of Autoimmunity, 1997
- Immunoregulatory and Cytokine Imbalances in the Pathogenesis of IDDM: Therapeutic Intervention by Immunostimulation?Diabetes, 1994
- Anti-interleukin-2 receptor monoclonal antibody therapy induces anti-idiotypic antibodies in mice that block both in vitro and in vivo activityJournal of Autoimmunity, 1988
- Possible role for the glucose-fatty acid cycle in dexamethasone-induced insulin antagonism in ratsMetabolism, 1987